Peak Pharma

This book argues that we have reached the ‘peak’ of a particular model for pharmaceutical innovation—the neoliberal value model that has been in place since the early 1980s. ‘Peak’ designates a state where a given and socially significant resource becomes rarer, more difficult to access, and more ex...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Geiger, Susi, Bourgeron, Théo
Formatua:	Online
Hizkuntza:	ingelesa
Argitaratua:	Oxford University Press 2026
Gaiak:	Health social movements Patient organizations Market failures Neoliberal regime Pharmaceutical markets Commons Political economy of pharmaceuticals Access to medicines Patents thema EDItEUR::K Economics, Finance, Business and Management::KC Economics::KCV Economics of specific sectors::KCVJ Health economics thema EDItEUR::K Economics, Finance, Business and Management::KC Economics thema EDItEUR::J Society and Social Sciences::JH Sociology and anthropology::JHB Sociology
Sarrera elektronikoa:	https://library.oapen.org/handle/20.500.12657/111395
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!